in-vitro and in-vitro antiinflammtory activity of proton pump inhibitors

1
Invitro Activity of PPIs on mouse macrophage RAW264.7 cell line Lansoprazole ,Omepra zol,Esmoprazol In Vivo Activity of Omeprazol on carrageenan -induced rat paw edema LPS and H.pylori induced TNF- αand IL-1βproductionco- incubated with human neutrophils and human umbilical cord endothelial cells inhibit the H. pylori extract induced expression of CD11b and CD18 on neutrophils and neutrophil-dependent adhesion to endothelial Anti-oxidant at and anti-inflammatory efficacy at an intraperitoneal dose of 2.5 mg/kg INTRODUCTION PPIs omeprazole, lansoprazole, pantoprazole, esomeprazole, rabeprazole were purchased Swapnroop chemicals, Aurangabad, India. Lambda carrageenan (22049 Sigma) and Thiazolyl Blue Tetrazolium Blue – MTT (M 2128 Sigma), Diclofenac sodium was generously supplied by Lord Venky Pharma Private Limited, Yanam, India. ELISA kits for determination of mouse TNF-α, IL-6 and IL-1β were purchased from eBioscience (San Diego, USA). Macrophage cell line, RAW 264.7 (ATCC TIB-71), was obtained from the American Type Culture Collection, Manassas, VA, USA. MATERIAL EXPERIMENTAL PROTOCOL Invitro Technique Invivo Technique Experimental Animl group Adult spargue Dawley Male Rat ,11 treatment groups containing 6 rats each. The acute in vivo antiphlogistic activity of PPIs was tested at 15, 30 and 60 mg/kg oral doses. Orally administered diclofenac sodium (5 mg/kg) served as a standard drug. Nitric Oxide Measurme ment Carrageenan Induced paw inflammatio n and Mechanical Hyper Algesia RESULT 10 20 50 100 200 300 400 0 10 20 30 40 50 60 70 80 90 100 110 Effect of different PPIs on % survival of RAW 264.7 cells OPZ LPZ PPZ RBZ EMZ Conc of drug in uM % Survival Name of drug Omeprazole Lansoprazo le Pantoprazo le Rabeprazol e Esomeprazo le IC 50 341.3 uM 149 uM 498 uM 146 uM 420 uM % survival at 50 uM 100 80 82 85 99 % Survival at 400 uM 39 14 40 15 51 PPIs inhibit the LPS-induced cytokine release from RAW-264.7 cells % survival at 50 uM 100 80 82 85 99 % Survival at 400 uM 39 14 40 15 51 PPIs inhibit carrageenan-induced acute paw inflammation in rats 1 hr 4 hr 1 hr 4 hr 1 hr 4 hr 1 hr 4 hr 0 5 10 15 20 25 30 35 40 45 OPZ LPZ PPZ EPZ RPZ 15 m g/kg 30 m g/kg 60 m g/kg Norm al C arrageenan Standard @ a a b b b b b b c b b c c c b *** *** *** ** *** ** c *** *** *** *** *** *** *** *** ** @ % R ise in paw volum e Figure 1: PPIs inhibit carrageenan induced acute paw inflammation in rats 15 mg/kg 30 mg/kg 60 mg.kg 0 5 10 15 20 25 30 35 40 45 50 55 Normal Carrageenan Standard OPZ LPZ PPZ EPZ RPZ @ a a a a a a a a a b b c b b b c Treatment Paw w ithdraw althreshold (g) 1hr 4hr 1hr 4hr 1hr 4hr 1hr 4hr 0 5 10 15 20 25 30 35 40 45 OPZ LPZ PPZ EPZ RPZ 15mg/kg 30mg/kg 60mg/kg Normal Carrageenan Standard @ a a b b b b b b c b b c c c b *** *** *** ** *** ** c *** *** *** *** *** *** *** *** ** @ % R ise in paw volum e Effects of PPIs on the viability (% Survival) of RAW264.7 murine macrophages. Cells were incubated with various concentrations of PPIsfor 24 hr, and cell viability was determined by MTT assay.The results are expressed as means±SD. P<0.0001. 0 20 40 60 80 100 120 Treatm ent Tnf- level ( p g /m g ofp ro tein ) Effect of PPIs on TNF-α level in Paw tissue supernatant of carrageenan injected animal. 0 5000 10000 15000 20000 25000 a* a* a*b* a* a* a*b* Treatm ent IL -6 le ve l (p g /m g o f protein) Effect of PPIs on IL-6 level in Paw tissue supernatant of carrageenan injected animal. 0 5000 10000 15000 20000 25000 a* a* a*b* a* a* a* Treatm ent IL-1 le v e l (p g /m g o f p ro tein ) Effect of PPIs on IL-1β level in Paw tissue supernatant of carrageenan injected animal DISCUSSION AND CONCLUSION Both In-vivo and In-vitro anti-inflammatory activity of Proton Pump Inhibitor was investigated. There were three major findings in our study. First, PPIs reduced the rise in paw volume, by dose dependent manner and also reduced the pain in inflamed condition. Second, the suppression of NO production at the initial stage of inflammation and third, in RAW 264.7 cell line PPIs exert anti-inflammatory effects through inhibition of the production of pro-inflammatory cytokine TNF-α, IL-1β and IL-6 from LPS stimulated macrophages In conclusion, the overall results of this study clearly indicate that the Proton pump inhibitor had higher anti-inflammatory and cytokine inhibitory action at increasing dose. Although the exact mechanism(s) of Proton pump inhibitors on suppressing the cytokine were not investigated in the present study, this could constitute an area of future studies REFERENCE 1) Nakagawa, Fumiyo, et al. "Projected life expectancy of people with HIV according to timing of diagnosis." Aids 26.3 (2012): 335-343. 2) Yoshida, Naoki, et al. "Weakly self-interacting dark matter and the structure of dark halos." The Astrophysical Journal Letters 544.2 (2000): L87. 3) Takagi, Takeshi, et al. "Decreased expression of microRNA-143 and-145 in human gastric cancers." Oncology 77.1 (2009): 12-21. 4) Ittiyavirah, Sibi P., and M. S. Shenika. "Evaluation of antioxidant and anti-inflammatory activity of Omeprazole against experimentally induced colitis."Journal of Scientific and Innovative Research 3.3 (2014): 352-356. 5) El-Nezhawy, Ahmed OH, et al. "Design, synthesis and pharmacological evaluation of omeprazole-like agents with anti-inflammatory activity."Bioorganic & medicinal chemistry 21.7 (2013): 1661-1670. 6) Thompson, J. E., R. P. Walker, and D. J. Faulkner. "Screening and bioassays for biologically-active substances from forty marine sponge species from San Diego, California, USA." Marine Biology 88.1 (1985): 11-21. 7) Patil, Kalpesh R., et al. "Pentacyclic Triterpenoids Inhibit IKKβ Mediated Activation of NF-κB Pathway: In Silico and In Vitro Evidences." PloS one 10.5 (2015): e0125709 8) Ntandou, GF Nsonde, et al. "Analgesic and anti-inflammatory effects of Cassia siamea Lam. stem bark extracts." Journal of ethnopharmacology127.1 (2010): 108-111.. 9) Fehrenbacher, Jill C., Michael R. Vasko, and Djane B. Duarte. "Models of Inflammation: Carrageenan‐or Complete Freund's Adjuvant (CFA)–Induced Edema and Hypersensitivity in the Rat." Current Protocols in Pharmacology(2012): 5-4. 10) Negro, C., L. Tommasi, and A. Miceli. "Phenolic compounds and antioxidant activity from red grape marc extracts." Bioresource Technology 87.1 (2003): 41-44. 11) Laszlo references preparation of “clayfen” from both K 10 bentonite and K 10 montmorillonite — see ref. 15 in Laszlo, P. et al. Tetrahedron Lett. 1984, 25, 3701 (our 12) Salvemini, Daniela, et al. "Nitric oxide: a key mediator in the early and late phase of carrageenan‐induced rat paw inflammation." British journal of pharmacology 118.4 (1996): 829-838. 13) Di Rosa, M. L., J. P. Giroud, and D. A. Willoughby. "Studies of the mediators of the acute inflammatory response induced in rats in different sites by carrageenan and turpentine." The Journal of pathology 104.1 (1971): 15-29. 14) Li, Xue-Qing, et al. "Comparison of inhibitory effects of the proton pump-inhibiting drugs omeprazole, esomeprazole, lansoprazole, pantoprazole, and rabeprazole on human cytochrome P450 activities" Drug metabolism “. 15) Hyun, Jong Jin, et al. "Effect of omeprazole on the expression of transcription factors in osteoclasts and osteoblasts." International journal of molecular medicine 26.6 (2010): 877. 16) Choy, Ernest HS, and Gabriel S. Panayi. "Cytokine pathways and joint inflammation in rheumatoid arthritis." New England Journal of Medicine344.12 (2001): 907-916. 17) Chavez, Sherry A., et al. "Development of β-amino alcohol derivatives that inhibit Toll-like receptor 4 mediated inflammatory response as potential antiseptics." Journal of medicinal chemistry 54.13 (2011): 4659-4669. In-vitro and In-vivo anti-inflammatory activity of proton pump inhibitors Department of Pharmacology,(contact no.-9158830005, email [email protected]) R. C. Patel Institute of Pharmaceutical Education & Research, Shirpur- 425405, Maharashtra, India Sanket Gandhi , Jayesh Patil, Umesh B. Mahajan, Sameer N. Goyal, Chandragouda R. Patil* Effect of PPIs on viability of RAW 264.7 cell By MTT Assay Effect of PPIs on Cytokinin release from RAW 264.7 cell cytokin es levels TNF-a, IL1 and IL6 levels by ELISA

Upload: shital-magar

Post on 21-Mar-2017

10 views

Category:

Health & Medicine


0 download

TRANSCRIPT

Page 1: In-Vitro and In-Vitro antiinflammtory activity of proton pump inhibitors

Invitro Activity of

PPIs on mouse macrophage

RAW264.7 cell line

Lansoprazole ,Omeprazol,Esmoprazol

In Vivo Activity of

Omeprazol on carrageenan-induced rat paw edema

LPS and H.pylori induced TNF-αand IL-1βproductionco-incubated with human neutrophils and human umbilical cord endothelial cells

inhibit the H. pylori extract induced expression of CD11b and CD18 on neutrophils and

neutrophil-dependent adhesion to endothelial

Anti-oxidant at and anti-inflammatory

efficacy at an intraperitoneal dose of

2.5 mg/kg

INTRODUCTION PPIs omeprazole,

lansoprazole, pantoprazole, esomeprazole, rabeprazole were purchased Swapnroop

chemicals, Aurangabad, India. Lambda carrageenan (22049 Sigma) and Thiazolyl Blue Tetrazolium Blue – MTT (M 2128 Sigma), Diclofenac sodium was generously supplied by Lord Venky Pharma Private Limited, Yanam, India. ELISA kits for determination of mouse TNF-α, IL-6 and IL-1β were purchased from eBioscience (San Diego, USA). Macrophage cell line, RAW 264.7 (ATCC TIB-71), was obtained from the American Type Culture Collection, Manassas, VA, USA.

MATERIAL EXPERIMENTAL PROTOCOL

Invitro Technique Invivo Technique

Experimental Animl group

Adult spargue Dawley Male

Rat ,11 treatment groups containing 6 rats each. The

acute in vivo antiphlogistic

activity of PPIs was tested at 15, 30

and 60 mg/kg oral doses.Orally

administered diclofenac sodium (5 mg/kg) served

as a standard drug.

Nitric Oxide

Measurmement

Carrageenan Induced paw inflammation

and Mechanical

Hyper AlgesiaRESULT

10 20 50 100 200 300 4000102030405060708090

100110

Effect of different PPIs on % survival of RAW 264.7 cells

OPZ LPZ PPZ RBZ EMZ

Conc of drug in uM

% S

urvi

val

Name of drug Omeprazole Lansoprazole Pantoprazole Rabeprazole Esomeprazole

IC 50 341.3 uM 149 uM 498 uM 146 uM 420 uM

% survival at 50 uM

100 80 82 85 99

% Survival at 400 uM

39 14 40 15 51

PPIs inhibit the LPS-induced cytokine release from RAW-264.7 cells

% survival at 50 uM

100 80 82 85 99

% Survival at 400 uM

39 14 40 15 51

 PPIs inhibit carrageenan-induced acute paw inflammation in rats

1 hr 4 hr 1 hr 4 hr 1 hr 4 hr 1 hr 4 hr0

5

10

15

20

25

30

35

40

45OPZ LPZ PPZ EPZ RPZ

15 mg/kg 30 mg/kg 60 mg/kg

Normal Carrageenan Standard

@

aa

b bb

b bb

c

bb

c

c cb

***

***

***

**

***

** c ***

***

******

***

***

***

***

**

@

% R

ise

in p

aw

vo

lum

e

 Figure 1: PPIs inhibit carrageenan induced acute paw inflammation in rats

15 mg/kg 30 mg/kg 60 mg.kg05

10152025303540455055

Normal Carrageenan Standard OPZ LPZ PPZ EPZ RPZ

@

a a a

a aa a a a

b b c

b b bc

Treatment

Pa

w w

ith

dra

wa

l th

resh

old

(g

)

1 hr 4 hr 1 hr 4 hr 1 hr 4 hr 1 hr 4 hr0

5

10

15

20

25

30

35

40

45OPZ LPZ PPZ EPZ RPZ

15 mg/kg 30 mg/kg 60 mg/kg

Normal Carrageenan Standard

@

aa

b bb

b bb

c

bb

c

c cb

***

***

***

**

***

** c ***

***

******

******

***

***

**

@

% R

ise

in p

aw

vo

lum

e

Effects of PPIs on the viability (% Survival) of RAW264.7 murine macrophages. Cells were incubated with various concentrations of PPIsfor 24 hr, and cell viability was determined by MTT assay.The results are expressed as means±SD. P<0.0001.

0

20

40

60

80

100

120

Treatment

Tnf-

leve

l ( p

g/m

g of

pro

tein

)

Effect of PPIs on TNF-α level in Paw tissue supernatant of carrageenan injected animal.

0

5000

10000

15000

20000

25000

a* a*a*b*

a*a* a*b*

Treatment

IL-6

leve

l (pg

/mg

of p

rote

in)

Effect of PPIs on IL-6 level in Paw tissue supernatant of carrageenan injected animal.

0

5000

10000

15000

20000

25000

a*a*

a*b*a*

a* a*

Treatment

IL-1

leve

l (pg

/mg

of p

rote

in)

  Effect of PPIs on IL-1β level in Paw tissue supernatant of carrageenan injected animal

DISCUSSION AND CONCLUSION Both In-vivo and In-vitro anti-inflammatory activity of Proton Pump Inhibitor was investigated. There were

three major findings in our study. First, PPIs reduced the rise in paw volume, by dose dependent manner and also reduced the pain in inflamed condition. Second, the suppression of NO production at the initial stage of

inflammation and third, in RAW 264.7 cell line PPIs exert anti-inflammatory effects through inhibition of the production of pro-inflammatory cytokine TNF-α, IL-1β and IL-6 from LPS stimulated macrophages

In conclusion, the overall results of this study clearly indicate that the Proton pump inhibitor had higher anti-inflammatory and cytokine inhibitory action at increasing dose. Although the exact mechanism(s) of Proton pump inhibitors on suppressing the cytokine were not investigated in the present study, this could constitute an area of

future studies

REFERENCE1) Nakagawa, Fumiyo, et al. "Projected life expectancy of people with HIV according to timing of diagnosis." Aids 26.3 (2012): 335-343.2) Yoshida, Naoki, et al. "Weakly self-interacting dark matter and the structure of dark halos." The Astrophysical Journal Letters 544.2 (2000): L87.3) Takagi, Takeshi, et al. "Decreased expression of microRNA-143 and-145 in human gastric cancers." Oncology 77.1 (2009): 12-21.4) Ittiyavirah, Sibi P., and M. S. Shenika. "Evaluation of antioxidant and anti-inflammatory activity of Omeprazole against experimentally induced colitis." Journal of Scientific and Innovative Research 3.3 (2014): 352-356.5) El-Nezhawy, Ahmed OH, et al. "Design, synthesis and pharmacological evaluation of omeprazole-like agents with anti-inflammatory activity."Bioorganic & medicinal chemistry 21.7 (2013): 1661-1670.6) Thompson, J. E., R. P. Walker, and D. J. Faulkner. "Screening and bioassays for biologically-active substances from forty marine sponge species from San Diego, California, USA." Marine Biology 88.1 (1985): 11-21.7) Patil, Kalpesh R., et al. "Pentacyclic Triterpenoids Inhibit IKKβ Mediated Activation of NF-κB Pathway: In Silico and In Vitro Evidences." PloS one 10.5 (2015): e01257098) Ntandou, GF Nsonde, et al. "Analgesic and anti-inflammatory effects of Cassia siamea Lam. stem bark extracts." Journal of ethnopharmacology127.1 (2010): 108-111..9) Fehrenbacher, Jill C., Michael R. Vasko, and Djane B. Duarte. "Models of Inflammation: Carrageenan‐or Complete Freund's Adjuvant (CFA)–Induced Edema and Hypersensitivity in the Rat." Current Protocols in Pharmacology(2012): 5-4.10) Negro, C., L. Tommasi, and A. Miceli. "Phenolic compounds and antioxidant activity from red grape marc extracts." Bioresource Technology 87.1 (2003): 41-44.11) Laszlo references preparation of “clayfen” from both K 10 bentonite and K 10 montmorillonite — see ref. 15 in Laszlo, P. et al. Tetrahedron Lett. 1984, 25, 3701 (our 12) Salvemini, Daniela, et al. "Nitric oxide: a key mediator in the early and late phase of carrageenan‐induced rat paw inflammation." British journal of pharmacology 118.4 (1996): 829-838.13) Di Rosa, M. L., J. P. Giroud, and D. A. Willoughby. "Studies of the mediators of the acute inflammatory response induced in rats in different sites by carrageenan and turpentine." The Journal of pathology 104.1 (1971): 15-29.14) Li, Xue-Qing, et al. "Comparison of inhibitory effects of the proton pump-inhibiting drugs omeprazole, esomeprazole, lansoprazole, pantoprazole, and rabeprazole on human cytochrome P450 activities" Drug metabolism “.15) Hyun, Jong Jin, et al. "Effect of omeprazole on the expression of transcription factors in osteoclasts and osteoblasts." International journal of molecular medicine 26.6 (2010): 877.16) Choy, Ernest HS, and Gabriel S. Panayi. "Cytokine pathways and joint inflammation in rheumatoid arthritis." New England Journal of Medicine344.12 (2001): 907-916.17) Chavez, Sherry A., et al. "Development of β-amino alcohol derivatives that inhibit Toll-like receptor 4 mediated inflammatory response as potential antiseptics." Journal of medicinal chemistry 54.13 (2011): 4659-4669.

In-vitro and In-vivo anti-inflammatory activity of proton pump inhibitors

Department of Pharmacology,(contact no.-9158830005, email [email protected])R. C. Patel Institute of Pharmaceutical Education &

Research, Shirpur- 425405, Maharashtra, IndiaSanket Gandhi, Jayesh Patil, Umesh B. Mahajan, Sameer N. Goyal, Chandragouda R. Patil*

Effect of PPIs on viability of RAW 264.7 cell

By MTT

Assay

Effect of PPIs on Cytokinin release from

RAW 264.7 cell

cytokines levels TNF-a, IL1 and

IL6 levels by ELISA